×
Chemed Revenue 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed revenue for the twelve months ending September 30, 2024 was
$2.377B
, a
6.83% increase
year-over-year.
Chemed annual revenue for 2023 was
$2.264B
, a
6.06% increase
from 2022.
Chemed annual revenue for 2022 was
$2.135B
, a
0.2% decline
from 2021.
Chemed annual revenue for 2021 was
$2.139B
, a
2.87% increase
from 2020.
View More
Chemed Revenue 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed annual revenue for 2023 was
$2.264B
, a
6.06% increase
from 2022.
Chemed annual revenue for 2022 was
$2.135B
, a
0.2% decline
from 2021.
Chemed annual revenue for 2021 was
$2.139B
, a
2.87% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$19.5B
Quest Diagnostics (DGX)
$18B
DaVita (DVA)
$12.9B
Encompass Health (EHC)
$10B
Elanco Animal Health (ELAN)
$6.6B
RadNet (RDNT)
$5.9B
Option Care Health (OPCH)
$3.7B
Amedisys (AMED)
$2.9B
LifeStance Health (LFST)
$2.8B
Astrana Health (ASTH)
$2.3B
Addus HomeCare (ADUS)
$2.2B
U.S Physical Therapy (USPH)
$1.4B
Aveanna Healthcare Holdings (AVAH)
$1.1B
Pennant (PNTG)
$1.1B
Atai Life Sciences (ATAI)
$290M
Daxor (DXR)
$43M
MEDIROM Healthcare Technologies (MRM)
$15M
Psychemedics (PMD)
$14M
ATI Physical Therapy (ATIP)
$8M
Ontrak (OTRK)
$8M
IMAC Holdings (BACK)
$1M